AlphAIAlphAI — Financial news for AI agents
247wallst.comOCT 302 min read

Kenvue Q3 2026: Revenue Beats as Kimberly-Clark Deal Nears Close

Kenvue reported Q3 2026 net sales of $3.89B, exceeding expectations. Adjusted EPS was $0.29, missing estimates due to a higher tax rate. Self Care revenue grew 5.9%, while Skin Health and Beauty remained flat. Operating income increased 12.2% YoY to $706M. The company did not provide guidance or hold an earnings call due to the pending Kimberly-Clark deal. CEO Kirk Perry stated the business transformation is progressing as planned.

Original reporting
247wallst.com
Published Oct 30, 2026, 10:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 11:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Kenvue Q3 2026: Revenue Beats as Kimberly-Clark Deal Nears Close — source image
Source · 247wallst.com
Decision brief

The 30-second read

Med
01

Why it matters

The earnings release provides fresh data on sales growth and profitability, influencing trader expectations ahead of the merger finalization.

02

Market read

Kenvue's earnings and merger progress are material for consumer health sector investors and may affect related stocks.

03

What to watch

Higher effective tax rate and lack of guidance may weigh on near-term sentiment.

Relevance 8/10Novelty 8/10Timing: post-market release

Background

Kenvue is the consumer health spinoff of Kimberly-Clark, with the merger expected to close soon.

Market effects

Sector

Consumer health sector may see pressure as the Kimberly-Clark merger integration timeline remains uncertain.

Regional

North American consumer staples could be affected by the pending merger.

Global

Limited to investors tracking the merger and earnings of major consumer health companies.

Counterpoint

What could challenge this read

Despite EPS miss, the revenue beat and merger synergies could support a longer-term upside.

Key entities

  • Company
    Kenvue

    Consumer health company reporting Q3 2026 results.

  • Company
    Kimberly-Clark

    Merger partner whose combination with Kenvue is nearing completion.

Read at source← All news

StoryKenvue posts Q3 2026 earnings amid pending Kimberly‑Clark merger

Also covered by

4 outlets

Related articles

OCT 30
$OKTAHighAI 8/10

Okta to Replace Kenvue in S&P 500 Amid Kimberly-Clark Acquisition

S&P Dow Jones Indices announced Okta (OKTA) will replace Kenvue (KVUE) in the S&P 500 on November 4, 2026, due to Kenvue's acquisition by Kimberly-Clark (KMB). Kenvue's valuation is $48.7B, with a $21.01 per-share consideration. Glaukos (GKOS) will replace Okta in the S&P MidCap 400, and McGrath RentCorp (MGRC) will replace Glaukos in the S&P SmallCap 600. Loar Holdings (LOAR) will replace LiveRamp (RAMP) in the S&P SmallCap 600 due to LiveRamp's acquisition by Publicis Groupe (PU4.DE).

securities.io3 min
OCT 30
$KVUEMedAI 8/10

Kenvue Q3 2026: Sales Up 3.2% to $3.89B, Adjusted EPS $0.29, No Guidance on Kimberly-Clark Deal

Kenvue Inc. (NYSE: KVUE) reported Q3 2026 net sales of $3.89B, up 3.2% YoY, with adjusted EPS of $0.29. Gross and operating margins improved, driven by supply-chain savings and tariff refunds. Self Care and Essential Health segments grew, while Skin Health and Beauty lagged. Free cash flow rose to $1.6B. No guidance was provided due to the pending Kimberly-Clark deal.

minichart.com.sg2 min
OCT 30
$KVUEHighAI 8/10

Kenvue posts higher profit, fourth straight sales gain in Q3 earnings

Kenvue reported Q3 adjusted earnings per share of 29 cents, up from 28 cents, and organic sales growth of 2.9%. Revenue exceeded $3.86 billion, matching analyst estimates. Self Care net sales rose 5.9%, while Skin Health and Beauty saw a slight decline. Gross and operating margins improved, and free cash flow increased. CEO Kirk Perry noted progress in operational overhaul and the pending combination with Kimberly-Clark.

qz.com2 min
OCT 30
$KVUEMed

Kenvue Delivers Fourth Consecutive Quarter of Sales Growth

Kenvue reported Q3 2026 net sales growth of 3.2% and organic sales growth of 2.9%, marking four consecutive quarters of sales growth. CEO Kirk Perry attributed the performance to strong execution, productivity initiatives, and brand investments. Skin Health & Beauty sales declined slightly, while Hair Care saw double-digit growth. Self Care segment increased by 5.9%. The company is on track for its business transformation and upcoming combination with Kimberly-Clark.

beautypackaging.com2 min
OCT 30
$KVUEHighAI 9/10

Kenvue Q3 Sales Rise 3.2% as EPS Increases 5%

Kenvue reported Q3 2026 net sales growth of 3.2% to $4.1B, with EPS up 5% to $0.22. Organic sales rose 2.9%, driven by volume growth and value realization. Gross and operating margins improved, while cash flow increased. The company did not provide guidance due to its pending merger with Kimberly-Clark.

grafa.com2 min